APO Research, Inc.

APO RESEARCH · REPORT

Cosmetic Peptide Synthesis

Selected research

Market Analysis & Forecast

Global Cosmetic Peptide Synthesis Market Analysis and Forecast 2026-2032

Market perspective

The global Cosmetic Peptide Synthesis market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Cosmetic Peptide Synthesis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Cosmetic Peptide Synthesis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Cosmetic Peptide Synthesis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Cosmetic Peptide Synthesis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Cosmetic Peptide Synthesis include Activotec, Bio-Synthesis, Apeptide, CPC Scientific Inc., LifeTein, AmbioPharm, GL Biochem, AAPPTec and otwo biotech, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Cosmetic Peptide Synthesis, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Cosmetic Peptide Synthesis, also provides the revenue of main regions and countries. Of the upcoming market potential for Cosmetic Peptide Synthesis, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cosmetic Peptide Synthesis revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cosmetic Peptide Synthesis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Cosmetic Peptide Synthesis revenue, projected growth trends, production technology, application and end-user industry.

Cosmetic Peptide Synthesis Segment by Company

Activotec

Bio-Synthesis

Apeptide

CPC Scientific Inc.

LifeTein

AmbioPharm

GL Biochem

AAPPTec

otwo biotech

Creative Peptides

RS Synthesis, LLC

Bio Basic Inc

GenScript

ProteoGenix

Bachem Inc.

Cosmetic Peptide Synthesis Segment by Type

Solid-Phase Peptide Synthesis

Liquid-Phase Peptide Synthesis

Others

Cosmetic Peptide Synthesis Segment by Application

Anti-aging

Eye Care

Anti-pigmentation

Hair Growth

Others

Cosmetic Peptide Synthesis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cosmetic Peptide Synthesis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cosmetic Peptide Synthesis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cosmetic Peptide Synthesis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Cosmetic Peptide Synthesis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Cosmetic Peptide Synthesis company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cosmetic Peptide Synthesis revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cosmetic Peptide Synthesis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Solid-Phase Peptide Synthesis Major Player Table 3. Liquid-Phase Peptide Synthesis Major Player Table 4. Others Major Player Table 5. Global Cosmetic Peptide Synthesis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Anti-aging Major Player Table 7. Eye Care Major Player Table 8. Anti-pigmentation Major Player Table 9. Hair Growth Major Player Table 10. Others Major Player Table 11. Cosmetic Peptide Synthesis Industry Trends Table 12. Cosmetic Peptide Synthesis Industry Drivers Table 13. Cosmetic Peptide Synthesis Industry Opportunities and Challenges Table 14. Cosmetic Peptide Synthesis Industry Restraints Table 15. Global Cosmetic Peptide Synthesis Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Cosmetic Peptide Synthesis Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Cosmetic Peptide Synthesis Market Share by Region (2021-2026) Table 18. Global Cosmetic Peptide Synthesis Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Cosmetic Peptide Synthesis Market Share by Region (2027-2032) Table 20. Global Cosmetic Peptide Synthesis Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Cosmetic Peptide Synthesis Revenue Market Share by Players (2021-2026) Table 22. Global Cosmetic Peptide Synthesis Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Cosmetic Peptide Synthesis Key Players Headquarters & Area Served Table 24. Global Cosmetic Peptide Synthesis Players, Product Type & Application Table 25. Global Cosmetic Peptide Synthesis Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Cosmetic Peptide Synthesis by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Cosmetic Peptide Synthesis Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Cosmetic Peptide Synthesis Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Cosmetic Peptide Synthesis Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Cosmetic Peptide Synthesis Revenue Market Share by Type (2021-2026) Table 32. Global Cosmetic Peptide Synthesis Revenue Market Share by Type (2027-2032) Table 33. Global Cosmetic Peptide Synthesis Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Cosmetic Peptide Synthesis Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Cosmetic Peptide Synthesis Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Cosmetic Peptide Synthesis Revenue Market Share by Application (2021-2026) Table 37. Global Cosmetic Peptide Synthesis Revenue Market Share by Application (2027-2032) Table 38. Activotec Company Information Table 39. Activotec Business Overview Table 40. Activotec Cosmetic Peptide Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Activotec Cosmetic Peptide Synthesis Product Portfolio Table 42. Activotec Recent Development Table 43. Bio-Synthesis Company Information Table 44. Bio-Synthesis Business Overview Table 45. Bio-Synthesis Cosmetic Peptide Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Bio-Synthesis Cosmetic Peptide Synthesis Product Portfolio Table 47. Bio-Synthesis Recent Development Table 48. Apeptide Company Information Table 49. Apeptide Business Overview Table 50. Apeptide Cosmetic Peptide Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Apeptide Cosmetic Peptide Synthesis Product Portfolio Table 52. Apeptide Recent Development Table 53. CPC Scientific Inc. Company Information Table 54. CPC Scientific Inc. Business Overview Table 55. CPC Scientific Inc. Cosmetic Peptide Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. CPC Scientific Inc. Cosmetic Peptide Synthesis Product Portfolio Table 57. CPC Scientific Inc. Recent Development Table 58. LifeTein Company Information Table 59. LifeTein Business Overview Table 60. LifeTein Cosmetic Peptide Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. LifeTein Cosmetic Peptide Synthesis Product Portfolio Table 62. LifeTein Recent Development Table 63. AmbioPharm Company Information Table 64. AmbioPharm Business Overview Table 65. AmbioPharm Cosmetic Peptide Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. AmbioPharm Cosmetic Peptide Synthesis Product Portfolio Table 67. AmbioPharm Recent Development Table 68. GL Biochem Company Information Table 69. GL Biochem Business Overview Table 70. GL Biochem Cosmetic Peptide Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. GL Biochem Cosmetic Peptide Synthesis Product Portfolio Table 72. GL Biochem Recent Development Table 73. AAPPTec Company Information Table 74. AAPPTec Business Overview Table 75. AAPPTec Cosmetic Peptide Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. AAPPTec Cosmetic Peptide Synthesis Product Portfolio Table 77. AAPPTec Recent Development Table 78. otwo biotech Company Information Table 79. otwo biotech Business Overview Table 80. otwo biotech Cosmetic Peptide Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. otwo biotech Cosmetic Peptide Synthesis Product Portfolio Table 82. otwo biotech Recent Development Table 83. Creative Peptides Company Information Table 84. Creative Peptides Business Overview Table 85. Creative Peptides Cosmetic Peptide Synthesis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Creative Peptides Cosmetic Peptide Synthesis Product Portfolio Table 87. Creative Peptides Recent Development Table 88. RS Synthesis, LLC Company Information Table 89. RS Synthesis, LLC Business Overview Table 90. RS Synthesis, LLC Cosmetic Peptide Synthesis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. RS Synthesis, LLC Cosmetic Peptide Synthesis Product Portfolio Table 92. RS Synthesis, LLC Recent Development Table 93. Bio Basic Inc Company Information Table 94. Bio Basic Inc Business Overview Table 95. Bio Basic Inc Cosmetic Peptide Synthesis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Bio Basic Inc Cosmetic Peptide Synthesis Product Portfolio Table 97. Bio Basic Inc Recent Development Table 98. GenScript Company Information Table 99. GenScript Business Overview Table 100. GenScript Cosmetic Peptide Synthesis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. GenScript Cosmetic Peptide Synthesis Product Portfolio Table 102. GenScript Recent Development Table 103. ProteoGenix Company Information Table 104. ProteoGenix Business Overview Table 105. ProteoGenix Cosmetic Peptide Synthesis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. ProteoGenix Cosmetic Peptide Synthesis Product Portfolio Table 107. ProteoGenix Recent Development Table 108. Bachem Inc. Company Information Table 109. Bachem Inc. Business Overview Table 110. Bachem Inc. Cosmetic Peptide Synthesis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Bachem Inc. Cosmetic Peptide Synthesis Product Portfolio Table 112. Bachem Inc. Recent Development Table 113. North America Cosmetic Peptide Synthesis Revenue by Type (2021-2026) & (US$ Million) Table 114. North America Cosmetic Peptide Synthesis Revenue by Type (2027-2032) & (US$ Million) Table 115. North America Cosmetic Peptide Synthesis Revenue by Application (2021-2026) & (US$ Million) Table 116. North America Cosmetic Peptide Synthesis Revenue by Application (2027-2032) & (US$ Million) Table 117. North America Cosmetic Peptide Synthesis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. North America Cosmetic Peptide Synthesis Revenue by Country (2021-2026) & (US$ Million) Table 119. North America Cosmetic Peptide Synthesis Revenue by Country (US$ Million) & (2027-2032) Table 120. Europe Cosmetic Peptide Synthesis Revenue by Type (2021-2026) & (US$ Million) Table 121. Europe Cosmetic Peptide Synthesis Revenue by Type (2027-2032) & (US$ Million) Table 122. Europe Cosmetic Peptide Synthesis Revenue by Application (2021-2026) & (US$ Million) Table 123. Europe Cosmetic Peptide Synthesis Revenue by Application (2027-2032) & (US$ Million) Table 124. Europe Cosmetic Peptide Synthesis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. Europe Cosmetic Peptide Synthesis Revenue by Country (2021-2026) & (US$ Million) Table 126. Europe Cosmetic Peptide Synthesis Revenue by Country (US$ Million) & (2027-2032) Table 127. China Cosmetic Peptide Synthesis Revenue by Type (2021-2026) & (US$ Million) Table 128. China Cosmetic Peptide Synthesis Revenue by Type (2027-2032) & (US$ Million) Table 129. China Cosmetic Peptide Synthesis Revenue by Application (2021-2026) & (US$ Million) Table 130. China Cosmetic Peptide Synthesis Revenue by Application (2027-2032) & (US$ Million) Table 131. Asia Cosmetic Peptide Synthesis Revenue by Type (2021-2026) & (US$ Million) Table 132. Asia Cosmetic Peptide Synthesis Revenue by Type (2027-2032) & (US$ Million) Table 133. Asia Cosmetic Peptide Synthesis Revenue by Application (2021-2026) & (US$ Million) Table 134. Asia Cosmetic Peptide Synthesis Revenue by Application (2027-2032) & (US$ Million) Table 135. Asia Cosmetic Peptide Synthesis Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 136. Asia Cosmetic Peptide Synthesis Revenue by Region (US$ Million) & (2021-2026) Table 137. Asia Cosmetic Peptide Synthesis Revenue by Region (US$ Million) & (2027-2032) Table 138. SAMEA Cosmetic Peptide Synthesis Revenue by Type (2021-2026) & (US$ Million) Table 139. SAMEA Cosmetic Peptide Synthesis Revenue by Type (2027-2032) & (US$ Million) Table 140. SAMEA Cosmetic Peptide Synthesis Revenue by Application (2021-2026) & (US$ Million) Table 141. SAMEA Cosmetic Peptide Synthesis Revenue by Application (2027-2032) & (US$ Million) Table 142. SAMEA Cosmetic Peptide Synthesis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. SAMEA Cosmetic Peptide Synthesis Revenue by Country (2021-2026) & (US$ Million) Table 144. SAMEA Cosmetic Peptide Synthesis Revenue by Country (US$ Million) & (2027-2032) Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Cosmetic Peptide Synthesis Image Figure 2. Global Cosmetic Peptide Synthesis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cosmetic Peptide Synthesis Market Size Share 2021 VS 2025 VS 2032 Figure 4. Solid-Phase Peptide Synthesis Image Figure 5. Liquid-Phase Peptide Synthesis Image Figure 6. Others Image Figure 7. Global Cosmetic Peptide Synthesis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Cosmetic Peptide Synthesis Market Size Share 2021 VS 2025 VS 2032 Figure 9. Anti-aging Image Figure 10. Eye Care Image Figure 11. Anti-pigmentation Image Figure 12. Hair Growth Image Figure 13. Others Image Figure 14. Global Cosmetic Peptide Synthesis Market Size (US$ Million) & (2021-2032) Figure 15. Global Cosmetic Peptide Synthesis Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Cosmetic Peptide Synthesis Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Cosmetic Peptide Synthesis Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Cosmetic Peptide Synthesis Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Cosmetic Peptide Synthesis Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Cosmetic Peptide Synthesis Revenue Market Share by Type (2021-2032) Figure 22. Global Cosmetic Peptide Synthesis Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Cosmetic Peptide Synthesis Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Cosmetic Peptide Synthesis Revenue Market Share by Application (2021-2032) Figure 25. North America Cosmetic Peptide Synthesis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Cosmetic Peptide Synthesis Revenue Share by Type (2021-2032) Figure 27. North America Cosmetic Peptide Synthesis Revenue Share by Application (2021-2032) Figure 28. North America Cosmetic Peptide Synthesis Revenue Share by Country (2021-2032) Figure 29. United States Cosmetic Peptide Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Cosmetic Peptide Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Cosmetic Peptide Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Cosmetic Peptide Synthesis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Cosmetic Peptide Synthesis Revenue Share by Type (2021-2032) Figure 34. Europe Cosmetic Peptide Synthesis Revenue Share by Application (2021-2032) Figure 35. Europe Cosmetic Peptide Synthesis Revenue Share by Country (2021-2032) Figure 36. Germany Cosmetic Peptide Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Cosmetic Peptide Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Cosmetic Peptide Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Cosmetic Peptide Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Cosmetic Peptide Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Cosmetic Peptide Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Cosmetic Peptide Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Cosmetic Peptide Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Cosmetic Peptide Synthesis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Cosmetic Peptide Synthesis Revenue Share by Type (2021-2032) Figure 46. China Cosmetic Peptide Synthesis Revenue Share by Application (2021-2032) Figure 47. Asia Cosmetic Peptide Synthesis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Cosmetic Peptide Synthesis Revenue Share by Type (2021-2032) Figure 49. Asia Cosmetic Peptide Synthesis Revenue Share by Application (2021-2032) Figure 50. Asia Cosmetic Peptide Synthesis Revenue Share by Region (2021-2032) Figure 51. Japan Cosmetic Peptide Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Cosmetic Peptide Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Cosmetic Peptide Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Cosmetic Peptide Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Cosmetic Peptide Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Cosmetic Peptide Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Cosmetic Peptide Synthesis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Cosmetic Peptide Synthesis Revenue Share by Type (2021-2032) Figure 59. SAMEA Cosmetic Peptide Synthesis Revenue Share by Application (2021-2032) Figure 60. SAMEA Cosmetic Peptide Synthesis Revenue Share by Country (2021-2032) Figure 61. Brazil Cosmetic Peptide Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Cosmetic Peptide Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Cosmetic Peptide Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Cosmetic Peptide Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Cosmetic Peptide Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Cosmetic Peptide Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Cosmetic Peptide Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Cosmetic Peptide Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Cosmetic Peptide Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Cosmetic Peptide Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Cosmetic Peptide Synthesis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Solid-Phase Peptide Synthesis
  • Liquid-Phase Peptide Synthesis
  • Others
Applications
  • Anti-aging
  • Eye Care
  • Anti-pigmentation
  • Hair Growth
  • Others
Companies covered
  • Activotec
  • Bio-Synthesis
  • Apeptide
  • CPC Scientific Inc.
  • LifeTein
  • AmbioPharm
  • GL Biochem
  • AAPPTec
  • otwo biotech
  • Creative Peptides
  • RS Synthesis, LLC
  • Bio Basic Inc
  • GenScript
  • ProteoGenix
  • Bachem Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Cosmetic Peptide Synthesis Market by Type
  3. 1.2.1 Global Cosmetic Peptide Synthesis Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Solid-Phase Peptide Synthesis
  5. 1.2.3 Liquid-Phase Peptide Synthesis
  6. 1.2.4 Others
  7. 1.3 Cosmetic Peptide Synthesis Market by Application
  8. 1.3.1 Global Cosmetic Peptide Synthesis Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Anti-aging
  10. 1.3.3 Eye Care
  11. 1.3.4 Anti-pigmentation
  12. 1.3.5 Hair Growth
  13. 1.3.6 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Cosmetic Peptide Synthesis Market Dynamics
  1. 2.1 Cosmetic Peptide Synthesis Industry Trends
  2. 2.2 Cosmetic Peptide Synthesis Industry Drivers
  3. 2.3 Cosmetic Peptide Synthesis Industry Opportunities and Challenges
  4. 2.4 Cosmetic Peptide Synthesis Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Cosmetic Peptide Synthesis Market Perspective (2021-2032)
  2. 3.2 Global Cosmetic Peptide Synthesis Growth Trends by Region
  3. 3.2.1 Global Cosmetic Peptide Synthesis Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Cosmetic Peptide Synthesis Market Size by Region (2021-2026)
  5. 3.2.3 Global Cosmetic Peptide Synthesis Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Cosmetic Peptide Synthesis Revenue by Players
  2. 4.1.1 Global Cosmetic Peptide Synthesis Revenue by Players (2021-2026)
  3. 4.1.2 Global Cosmetic Peptide Synthesis Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Cosmetic Peptide Synthesis Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Cosmetic Peptide Synthesis Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Cosmetic Peptide Synthesis Key Players Headquarters & Area Served
  7. 4.4 Global Cosmetic Peptide Synthesis Players, Product Type & Application
  8. 4.5 Global Cosmetic Peptide Synthesis Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Cosmetic Peptide Synthesis Market CR5 and HHI
  11. 4.6.3 2025 Cosmetic Peptide Synthesis Tier 1, Tier 2, and Tier 3
5 Cosmetic Peptide Synthesis Market Size by Type
  1. 5.1 Global Cosmetic Peptide Synthesis Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Cosmetic Peptide Synthesis Revenue by Type (2021-2032)
  3. 5.3 Global Cosmetic Peptide Synthesis Revenue Market Share by Type (2021-2032)
6 Cosmetic Peptide Synthesis Market Size by Application
  1. 6.1 Global Cosmetic Peptide Synthesis Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Cosmetic Peptide Synthesis Revenue by Application (2021-2032)
  3. 6.3 Global Cosmetic Peptide Synthesis Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Activotec
  2. 7.1.1 Activotec Company Information
  3. 7.1.2 Activotec Business Overview
  4. 7.1.3 Activotec Cosmetic Peptide Synthesis Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Activotec Cosmetic Peptide Synthesis Product Portfolio
  6. 7.1.5 Activotec Recent Developments
  7. 7.2 Bio-Synthesis
  8. 7.2.1 Bio-Synthesis Company Information
  9. 7.2.2 Bio-Synthesis Business Overview
  10. 7.2.3 Bio-Synthesis Cosmetic Peptide Synthesis Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Bio-Synthesis Cosmetic Peptide Synthesis Product Portfolio
  12. 7.2.5 Bio-Synthesis Recent Developments
  13. 7.3 Apeptide
  14. 7.3.1 Apeptide Company Information
  15. 7.3.2 Apeptide Business Overview
  16. 7.3.3 Apeptide Cosmetic Peptide Synthesis Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Apeptide Cosmetic Peptide Synthesis Product Portfolio
  18. 7.3.5 Apeptide Recent Developments
  19. 7.4 CPC Scientific Inc.
  20. 7.4.1 CPC Scientific Inc. Company Information
  21. 7.4.2 CPC Scientific Inc. Business Overview
  22. 7.4.3 CPC Scientific Inc. Cosmetic Peptide Synthesis Revenue and Gross Margin (2021-2026)
  23. 7.4.4 CPC Scientific Inc. Cosmetic Peptide Synthesis Product Portfolio
  24. 7.4.5 CPC Scientific Inc. Recent Developments
  25. 7.5 LifeTein
  26. 7.5.1 LifeTein Company Information
  27. 7.5.2 LifeTein Business Overview
  28. 7.5.3 LifeTein Cosmetic Peptide Synthesis Revenue and Gross Margin (2021-2026)
  29. 7.5.4 LifeTein Cosmetic Peptide Synthesis Product Portfolio
  30. 7.5.5 LifeTein Recent Developments
  31. 7.6 AmbioPharm
  32. 7.6.1 AmbioPharm Company Information
  33. 7.6.2 AmbioPharm Business Overview
  34. 7.6.3 AmbioPharm Cosmetic Peptide Synthesis Revenue and Gross Margin (2021-2026)
  35. 7.6.4 AmbioPharm Cosmetic Peptide Synthesis Product Portfolio
  36. 7.6.5 AmbioPharm Recent Developments
  37. 7.7 GL Biochem
  38. 7.7.1 GL Biochem Company Information
  39. 7.7.2 GL Biochem Business Overview
  40. 7.7.3 GL Biochem Cosmetic Peptide Synthesis Revenue and Gross Margin (2021-2026)
  41. 7.7.4 GL Biochem Cosmetic Peptide Synthesis Product Portfolio
  42. 7.7.5 GL Biochem Recent Developments
  43. 7.8 AAPPTec
  44. 7.8.1 AAPPTec Company Information
  45. 7.8.2 AAPPTec Business Overview
  46. 7.8.3 AAPPTec Cosmetic Peptide Synthesis Revenue and Gross Margin (2021-2026)
  47. 7.8.4 AAPPTec Cosmetic Peptide Synthesis Product Portfolio
  48. 7.8.5 AAPPTec Recent Developments
  49. 7.9 otwo biotech
  50. 7.9.1 otwo biotech Company Information
  51. 7.9.2 otwo biotech Business Overview
  52. 7.9.3 otwo biotech Cosmetic Peptide Synthesis Revenue and Gross Margin (2021-2026)
  53. 7.9.4 otwo biotech Cosmetic Peptide Synthesis Product Portfolio
  54. 7.9.5 otwo biotech Recent Developments
  55. 7.10 Creative Peptides
  56. 7.10.1 Creative Peptides Company Information
  57. 7.10.2 Creative Peptides Business Overview
  58. 7.10.3 Creative Peptides Cosmetic Peptide Synthesis Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Creative Peptides Cosmetic Peptide Synthesis Product Portfolio
  60. 7.10.5 Creative Peptides Recent Developments
  61. 7.11 RS Synthesis, LLC
  62. 7.11.1 RS Synthesis, LLC Company Information
  63. 7.11.2 RS Synthesis, LLC Business Overview
  64. 7.11.3 RS Synthesis, LLC Cosmetic Peptide Synthesis Revenue and Gross Margin (2021-2026)
  65. 7.11.4 RS Synthesis, LLC Cosmetic Peptide Synthesis Product Portfolio
  66. 7.11.5 RS Synthesis, LLC Recent Developments
  67. 7.12 Bio Basic Inc
  68. 7.12.1 Bio Basic Inc Company Information
  69. 7.12.2 Bio Basic Inc Business Overview
  70. 7.12.3 Bio Basic Inc Cosmetic Peptide Synthesis Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Bio Basic Inc Cosmetic Peptide Synthesis Product Portfolio
  72. 7.12.5 Bio Basic Inc Recent Developments
  73. 7.13 GenScript
  74. 7.13.1 GenScript Company Information
  75. 7.13.2 GenScript Business Overview
  76. 7.13.3 GenScript Cosmetic Peptide Synthesis Revenue and Gross Margin (2021-2026)
  77. 7.13.4 GenScript Cosmetic Peptide Synthesis Product Portfolio
  78. 7.13.5 GenScript Recent Developments
  79. 7.14 ProteoGenix
  80. 7.14.1 ProteoGenix Company Information
  81. 7.14.2 ProteoGenix Business Overview
  82. 7.14.3 ProteoGenix Cosmetic Peptide Synthesis Revenue and Gross Margin (2021-2026)
  83. 7.14.4 ProteoGenix Cosmetic Peptide Synthesis Product Portfolio
  84. 7.14.5 ProteoGenix Recent Developments
  85. 7.15 Bachem Inc.
  86. 7.15.1 Bachem Inc. Company Information
  87. 7.15.2 Bachem Inc. Business Overview
  88. 7.15.3 Bachem Inc. Cosmetic Peptide Synthesis Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Bachem Inc. Cosmetic Peptide Synthesis Product Portfolio
  90. 7.15.5 Bachem Inc. Recent Developments
8 North America
  1. 8.1 North America Cosmetic Peptide Synthesis Revenue (2021-2032)
  2. 8.2 North America Cosmetic Peptide Synthesis Revenue by Type (2021-2032)
  3. 8.2.1 North America Cosmetic Peptide Synthesis Revenue by Type (2021-2026)
  4. 8.2.2 North America Cosmetic Peptide Synthesis Revenue by Type (2027-2032)
  5. 8.3 North America Cosmetic Peptide Synthesis Revenue Share by Type (2021-2032)
  6. 8.4 North America Cosmetic Peptide Synthesis Revenue by Application (2021-2032)
  7. 8.4.1 North America Cosmetic Peptide Synthesis Revenue by Application (2021-2026)
  8. 8.4.2 North America Cosmetic Peptide Synthesis Revenue by Application (2027-2032)
  9. 8.5 North America Cosmetic Peptide Synthesis Revenue Share by Application (2021-2032)
  10. 8.6 North America Cosmetic Peptide Synthesis Revenue by Country
  11. 8.6.1 North America Cosmetic Peptide Synthesis Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Cosmetic Peptide Synthesis Revenue by Country (2021-2026)
  13. 8.6.3 North America Cosmetic Peptide Synthesis Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Cosmetic Peptide Synthesis Revenue (2021-2032)
  2. 9.2 Europe Cosmetic Peptide Synthesis Revenue by Type (2021-2032)
  3. 9.2.1 Europe Cosmetic Peptide Synthesis Revenue by Type (2021-2026)
  4. 9.2.2 Europe Cosmetic Peptide Synthesis Revenue by Type (2027-2032)
  5. 9.3 Europe Cosmetic Peptide Synthesis Revenue Share by Type (2021-2032)
  6. 9.4 Europe Cosmetic Peptide Synthesis Revenue by Application (2021-2032)
  7. 9.4.1 Europe Cosmetic Peptide Synthesis Revenue by Application (2021-2026)
  8. 9.4.2 Europe Cosmetic Peptide Synthesis Revenue by Application (2027-2032)
  9. 9.5 Europe Cosmetic Peptide Synthesis Revenue Share by Application (2021-2032)
  10. 9.6 Europe Cosmetic Peptide Synthesis Revenue by Country
  11. 9.6.1 Europe Cosmetic Peptide Synthesis Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Cosmetic Peptide Synthesis Revenue by Country (2021-2026)
  13. 9.6.3 Europe Cosmetic Peptide Synthesis Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Cosmetic Peptide Synthesis Revenue (2021-2032)
  2. 10.2 China Cosmetic Peptide Synthesis Revenue by Type (2021-2032)
  3. 10.2.1 China Cosmetic Peptide Synthesis Revenue by Type (2021-2026)
  4. 10.2.2 China Cosmetic Peptide Synthesis Revenue by Type (2027-2032)
  5. 10.3 China Cosmetic Peptide Synthesis Revenue Share by Type (2021-2032)
  6. 10.4 China Cosmetic Peptide Synthesis Revenue by Application (2021-2032)
  7. 10.4.1 China Cosmetic Peptide Synthesis Revenue by Application (2021-2026)
  8. 10.4.2 China Cosmetic Peptide Synthesis Revenue by Application (2027-2032)
  9. 10.5 China Cosmetic Peptide Synthesis Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Cosmetic Peptide Synthesis Revenue (2021-2032)
  2. 11.2 Asia Cosmetic Peptide Synthesis Revenue by Type (2021-2032)
  3. 11.2.1 Asia Cosmetic Peptide Synthesis Revenue by Type (2021-2026)
  4. 11.2.2 Asia Cosmetic Peptide Synthesis Revenue by Type (2027-2032)
  5. 11.3 Asia Cosmetic Peptide Synthesis Revenue Share by Type (2021-2032)
  6. 11.4 Asia Cosmetic Peptide Synthesis Revenue by Application (2021-2032)
  7. 11.4.1 Asia Cosmetic Peptide Synthesis Revenue by Application (2021-2026)
  8. 11.4.2 Asia Cosmetic Peptide Synthesis Revenue by Application (2027-2032)
  9. 11.5 Asia Cosmetic Peptide Synthesis Revenue Share by Application (2021-2032)
  10. 11.6 Asia Cosmetic Peptide Synthesis Revenue by Country
  11. 11.6.1 Asia Cosmetic Peptide Synthesis Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Cosmetic Peptide Synthesis Revenue by Country (2021-2026)
  13. 11.6.3 Asia Cosmetic Peptide Synthesis Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Cosmetic Peptide Synthesis Revenue (2021-2032)
  2. 12.2 SAMEA Cosmetic Peptide Synthesis Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Cosmetic Peptide Synthesis Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Cosmetic Peptide Synthesis Revenue by Type (2027-2032)
  5. 12.3 SAMEA Cosmetic Peptide Synthesis Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Cosmetic Peptide Synthesis Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Cosmetic Peptide Synthesis Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Cosmetic Peptide Synthesis Revenue by Application (2027-2032)
  9. 12.5 SAMEA Cosmetic Peptide Synthesis Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Cosmetic Peptide Synthesis Revenue by Country
  11. 12.6.1 SAMEA Cosmetic Peptide Synthesis Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Cosmetic Peptide Synthesis Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Cosmetic Peptide Synthesis Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.